HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Klamer Selected Research

Antipsychotic Agents (Antipsychotics)

4/2011L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study.
2/2005The effects of phencyclidine on latent inhibition in taste aversion conditioning: differential effects of preexposure and conditioning.
2/2004Phencyclidine-induced behaviour in mice prevented by methylene blue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel Klamer Research Topics

Disease

16Schizophrenia (Dementia Praecox)
04/2011 - 02/2004
5Cognitive Dysfunction
03/2011 - 07/2006
2Fragile X Syndrome (Martin Bell Syndrome)
01/2022 - 01/2021
2Rett Syndrome (Rett's Disorder)
01/2021 - 12/2019
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 12/2019
2Huntington Disease (Huntington's Disease)
01/2018 - 01/2014
2AIDS-Related Complex (ARC)
11/2014 - 01/2014
1Neurodevelopmental Disorders
01/2021
1Pathologic Processes
12/2019
1Disease Progression
01/2018
1Alcoholism (Alcohol Abuse)
05/2015
1Nervous System Diseases (Neurological Disorders)
05/2015
1Chorea (Rheumatic Chorea)
01/2014
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
04/2011
1Brain Diseases (Brain Disorder)
08/2008
1Psychotic Disorders (Schizoaffective Disorder)
05/2007

Drug/Important Bio-Agent (IBA)

14Phencyclidine (Angel Dust)IBA
03/2011 - 02/2004
6Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2015 - 02/2004
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
03/2011 - 04/2005
3N- dimethyl- 2,2- diphenyl- 3- furanmethanamine hydrochloride tetrahydro-NIBA
01/2022 - 12/2019
3Sigma-1 ReceptorIBA
01/2022 - 12/2019
3pridopidineIBA
01/2018 - 01/2014
3Dopamine (Intropin)FDA LinkGeneric
11/2014 - 04/2011
3Antipsychotic Agents (Antipsychotics)IBA
04/2011 - 02/2004
3Nitric Oxide Synthase (NO Synthase)IBA
12/2010 - 02/2004
2Haloperidol (Haldol)FDA LinkGeneric
11/2014 - 01/2014
23,4-Dihydroxyphenylacetic AcidIBA
11/2014 - 01/2014
2N-Methylaspartate (NMDA)IBA
11/2014 - 04/2005
2Glutamic Acid (Glutamate)FDA Link
03/2011 - 06/2009
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
12/2019
1CalciumIBA
12/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2015
1AntioxidantsIBA
05/2015
1Proteins (Proteins, Gene)FDA Link
11/2014
1RemoxiprideIBA
11/2014
1Dopamine D2 Receptor AntagonistsIBA
11/2014
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
11/2014
1Tetrabenazine (Nitoman)FDA Link
01/2014
1Messenger RNA (mRNA)IBA
01/2014
1Lysine (L-Lysine)FDA Link
04/2011
1Amino AcidsFDA Link
04/2011
1gamma-Aminobutyric Acid (GABA)IBA
06/2009
1AgmatineIBA
08/2008
1Neurotransmitter Agents (Neurotransmitter)IBA
08/2008
1Hallucinogens (Psychedelics)IBA
05/2008
1Dizocilpine Maleate (Dizocilpine)IBA
04/2005
1Methylene Blue (Methylthioninium Chloride)FDA Link
02/2004
1Guanylate Cyclase (Guanylyl Cyclase)IBA
02/2004

Therapy/Procedure

3Therapeutics
12/2010 - 02/2004